Adiposopathy: Role of adipocyte factors in a new paradigm

Expert Review of Cardiovascular Therapy

Volumn 3, Issue 2, 2005, Pages 187-189

  Bays, Harold ^a  

^a LOUISVILLE METABOLIC AND ATHEROSCLEROSIS RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION STIMULATING PROTEIN; ADIPONECTIN; ADIPSIN; ANGIOTENSIN; ANGIOTENSINOGEN; APOLIPOPROTEIN E; C REACTIVE PROTEIN; CATHEPSIN; CHOLESTEROL ESTER TRANSFER PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN; FATTY ACID; INSULIN; INTERLEUKIN 6; LEPTIN; LIPOPROTEIN LIPASE; LYSOPHOSPHOLIPID; MACROPHAGE MIGRATION INHIBITION FACTOR; METALLOPROTEINASE; NITRIC OXIDE SYNTHASE; PHOSPHOLIPID TRANSFER PROTEIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADIPOCYTE; ADIPOSOPATHY; ATHEROGENESIS; ATHEROSCLEROSIS; BODY FAT; CARDIOVASCULAR DISEASE; CELL SIZE; DIABETOGENESIS; DISEASE PREDISPOSITION; DYSLIPIDEMIA; EDITORIAL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; METABOLIC DISORDER; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PREVALENCE; PROTEIN FUNCTION; PROTEIN SECRETION;

ADIPOSE TISSUE; ADIPOSITY; BIOLOGICAL FACTORS; HUMANS; METABOLIC DISEASES;

EID: 15844367645     PISSN: 14779072     EISSN: None     Source Type: Journal    
DOI: 10.1586/14779072.3.2.187     Document Type: Editorial

References (4)

1. Bays H, Abate N, Chandalia M. Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia. Future Cardiol. 1(1), 39-59 (2005).
2. Karelis AD, St-Pierre DH, Conus F et al. Metabolic and body composition factors in subgroups of obesity: what do we know? J. Clin. Endocrinol. Metab. 89, 2569-2575 (2004).
3. Bays HE. Current and investigational antiobesity agents and obesity therapeutic treatment targets. Obes. Res. 12(8), 1197-1211 (2004).
4. Bays H, Mandarino L, DeFronzo RA. Role of the adipocyte, FFA and ectopic fat in pathogenesis of Type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 89, 463-478 (2004).